Search

Exercising is one of the greatest benefits for the health. However, at a systemic level it can be harmful depending on the intensity degree with which the athletes practice. The high-resistance training involves exhaustive training that can result in gastrointestinal symptoms and systemic manifestations occur such as the triggering of the inflammatory process, progression of oxidative stress and gut microbiota modification. Currently, athletes consume commercial products to counteract these effects. However, there are natural therapeutic alternatives such as the consumption of sources rich in dietary fiber and polyphenols. The use of these sources can improve the symptoms presented by reducing systemic oxidative processes, improving intestinal protection and increasing sports performance. This review it focuses on the systemic mechanisms modifiable by the high-resistance training and the consumption of natural sources as fiber and polyphenolic compounds a therapeutic alternative to reduce intestinal symptoms and negative systemic processes in the athlete and favor naturally their gut health. [ABSTRACT FROM AUTHOR]

Plant-derived nanovesicles (PDNVs) have recently emerged as natural delivery systems of biofunctional compounds toward mammalian cells. Considering their already described composition, anti-inflammatory properties, stability, and low toxicity, PDNVs offer a promising path for developing new preventive strategies for several inflammatory diseases, among which the inflammatory bowel disease (IBD). In this study, we explore the protective effects of industrially produced lemon vesicles (iLNVs) in a rat model of IBD. Characterization of iLNVs reveals the presence of small particles less than 200 nm in size and a profile of bioactive compounds enriched in flavonoids and organic acids with known beneficial properties. In vitro studies on human macrophages confirm the safety and anti-inflammatory effects of iLNVs, as evidenced by the reduced expression of pro-inflammatory cytokines and increased levels of anti-inflammatory markers. As evidenced by in vivo experiments, pre-treatment with iLNVs significantly alleviates symptoms and histological features in 2,4 dinitrobenzensulfuric acid (DNBS)-induced colitis in rats. Molecular pathway analysis reveals modulation of NF-κB and Nrf2, indicating anti-inflammatory and antioxidant effects. Finally, iLNVs affects gut microbiota composition, improving the consistent colitis-related alterations. Overall, we demonstrated the protective role of industrially produced lemon nanovesicles against colitis and emphasized their potential in managing IBD through multifaceted mechanisms. [Display omitted] • Lemon nanovesicles (iLNVs) play a protective role against DNBS-induced colitis in rat. • iLNVs decrease colitis-associated inflammatory damages. • iLNVs restore the rat intestinal permeability acting on tight junctions. • iLNVs shape the gut microbiota. [ABSTRACT FROM AUTHOR]